Today, only three major PBMs dominate the industry. And with so much power ... has never been greater. Even Big Pharma, often criticized for high prices, is now struggling to navigate this ecosystem.

DAVENPORT, Iowa (KWQC) - A celebration was held in Downtown Davenport for the Figge Art Museum’s debut of “Evanescent Field,” a monumental light sculpture by internationally renowned artist ...

Artist Antireal pointed out the use of her artwork in-game on social media, while tagging in the developer and franchise art director Joseph Cross. the Marathon alpha released recently and its ...

The Pharma industry may therefore believe that Trump's opening gambit will not be his last, and while they may have to sit around the negotiating table, it is highly unlikely they will end up ...

The British Society of Gastroenterology (BSG) has published new guidelines on colorectal cancer surveillance for patients with inflammatory bowel disease (IBD). Published in the BMJ journal Gut ...

the underlying factor for recognition is a pharma operations team that demonstrates the best capability relative to peers in the industry for a specific department, function or process.

I look forward to hosting Zoe in Washington and showcasing her artwork in our nation’s capital for all to see. Each spring, the Congressional Institute sponsors a nationwide high school visual ...

The pharma industry’s reputation has continued to slide — and it’s mostly due to the persistent issue of high drug costs, according to a report released by research firm PatientView this week.

MIFFLINBURG — Members of the public will have a chance to view and purchase student artwork in Mifflinburg. Mifflinburg Area Intermediate School art teacher Kaitlyn Carey organized the Art Club ...

The industry’s reputation surged during the COVID-19 pandemic, according to PatientView’s annual survey of patient groups, peaking two years ago, when 60% of those surveyed said pharma’s ...

Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating clinical trials and diagnosing rare diseases to validating traditional medicines.

Ms. Auffret’s group has already warned European officials that they must not hit back at an attack on the important industry by tariffing ... in that prediction. “Pharma needs more attractive ...